Four years after being treated for breast cancer, a quarter of survivors say they are worse off financially, at least partly because of their treatment, according to a new study led by University of Michigan Comprehensive Cancer Center researchers.
Shaomeng Wang has been selected to receive the Distinguished University Innovator Award for 2014. Sponsored by the Office of Research, the award honors faculty who have made important and lasting contributions to society by developing novel ideas and insights through their research, and then translating them to practice.
A new study, authored by Reshma Jagsi, M.D., D.Phil., associate professor of radiation oncology, finds gender differences in parenting and household labor persist among a group of highly motivated physician-researchers in the early stages of their career. The finding could shed light on why female academic physicians in general do not have the same career success as their male colleagues.
Researchers found that a majority of women who undergo mastectomy for breast cancer go on to get breast reconstruction, with rates rising dramatically over time. There are still geographic variations, and women who also have radiation tend to have lower rates of reconstruction.
New research from the University of Michigan Comprehensive Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an increase in cancer stem cells. This provides a potential target for treating triple negative breast cancer, the most aggressive form of the disease.
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to an international collaboration of researchers. Their finding sheds new light on the process that makes cancer a deadly disease.
The research and development spending in the United States dropped from $131 billion to $119 billion, when adjusted for inflation, from 2007-2012, while Japan increased spending by $9 billion and China increased by $6.4 billion. Overall, Asia's share of spending grew from 18 percent to 24 percent. Europe held steady at 29 percent.
Patients with tongue cancer who started their treatment with a course of chemotherapy fared significantly worse than patients who received surgery first, according to a new study from researchers at the U-M Cancer Center. This is contrary to protocols for larynx cancer, in which a single dose of chemotherapy helps determine which patients fare better with chemotherapy and radiation and which patients should elect for surgery. In larynx cancer, this approach, which was pioneered and extensively researched at U-M, has led to better patient survival and functional outcomes.
Researchers at the University of Michigan Comprehensive Cancer Center have discovered a new class of drugs which reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments.
Researchers unravel mystery of how leukemia-causing mutations enable pre-leukemic stem cells to outperform their healthy counterparts
Researchers at the Children's Medical Center Research Institute at UT Southwestern, the University of California at San Francisco and the University of Michigan Comprehensive Cancer Center have discovered how leukemia-causing mutations enable pre-leukemic stem cells to outperform their healthy counterparts.